لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Zogopoulos G; 1McGill University Health Centre, Montreal, Quebec, Canada., Haimi I; 2New York University Langone Health, New York, NY., Sanoba SA; 2New York University Langone Health, New York, NY., Everett JN; 2New York University Langone Health, New York, NY., Wang Y; 1McGill University Health Centre, Montreal, Quebec, Canada., Katona BW; 3University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Farrell JJ; 4Yale School of Medicine, Yale University, New Haven, CT., Grossberg AJ; 5Oregon Health & Science University, Portland, OR., Paiella S; 6General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona, Verona, Italy., Klute KA; 7University of Nebraska Medical Center, Omaha, NE., Bi Y; 8Mayo Clinic, Jacksonville, FL., Wallace MB; 8Mayo Clinic, Jacksonville, FL., Kwon RS; 9Michigan Medicine, Ann Arbor, MI., Stoffel EM; 9Michigan Medicine, Ann Arbor, MI., Wadlow RC; 10Inova Schar Cancer Institute, Fairfax, VA., Sussman DA; 11University of Miami Health System, Miami, FL., Merchant NB; 11University of Miami Health System, Miami, FL., Permuth JB; 12Moffitt Cancer Center, Tampa, FL., Golan T; 13Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Raitses-Gurevich M; 13Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Lowy AM; 14UC San Diego Health, La Jolla, CA., Liau J; 14UC San Diego Health, La Jolla, CA., Jeter JM; 15Huntsman Cancer Institute, Salt Lake City, UT., Lindberg JM; 16UMass Memorial Health, Worcester, MA., Chung DC; 17Massachusetts General Hospital and Harvard Medical School, Boston, MA., Earl J; 18Ramón y Cajal Health Research Institute, Madrid, Spain., Brentnall TA; 19University of Washington Medical Center, Seattle, WA., Schrader KA; 20BC Cancer, Vancouver, British Columbia, Canada., Kaul V; 21University of Rochester Medical Center, Rochester, NY., Huang C; 2New York University Langone Health, New York, NY., Chandarana H; 2New York University Langone Health, New York, NY., Smerdon C; 22Arbor Research Collaborative for Health, Ann Arbor, MI., Graff JJ; 22Arbor Research Collaborative for Health, Ann Arbor, MI., Kastrinos F; 23Columbia University Irving Medical Center/Herbert Irving Comprehensive Cancer Center, New York, NY., Kupfer SS; 24University of Chicago, Chicago, IL., Lucas AL; 25Icahn School of Medicine at Mount Sinai, New York, NY., Sears RC; 5Oregon Health & Science University, Portland, OR., Brand RE; 26University of Pittsburgh, Pittsburgh, PA., Parmigiani G; 27Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA., Simeone DM; 2New York University Langone Health, New York, NY.

مؤلفون مشاركون: PRECEDE Consortium

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Apr; Vol. 22 (3), pp. 158-166.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/diagnostic imaging , Pancreatic Neoplasms*/epidemiology , Adenocarcinoma*, Humans ; Early Detection of Cancer/methods ; Prospective Studies ; Genetic Predisposition to Disease ; Magnetic Resonance Imaging

المؤلفون: Kabbara KW, Cannon T, Winer A, Wadlow RC

المصدر: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2022 Aug 10; Vol. 36 (8), pp. 492-498.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

مواضيع طبية MeSH: Bile Duct Neoplasms*/drug therapy , Bile Duct Neoplasms*/therapy , Cholangiocarcinoma*/drug therapy , Cholangiocarcinoma*/therapy, Bile Ducts, Intrahepatic/pathology ; Genomics ; Humans ; Molecular Targeted Therapy ; Mutation ; Tumor Microenvironment/genetics

المؤلفون: Cannon TL; Inova Schar Cancer Institute., Randall JN BA; Inova Schar Cancer Institute., Sokol ES; Foundation Medicine., Alexander SM; MS, CRNP, AOCNP Foundation Medicine., Wadlow RC; Inova Schar Cancer Institute., Winer AA; Inova Schar Cancer Institute., Barnett DM; Virginia Commonwealth University., Rayes DL BS; University of Virginia., Nimeiri HS; Foundation Medicine., McGregor KA; Foundation Medicine.

المصدر: Cancer treatment and research communications [Cancer Treat Res Commun] 2022; Vol. 32, pp. 100569. Date of Electronic Publication: 2022 Apr 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/secondary , Proto-Oncogene Proteins B-raf*/genetics, Colonic Neoplasms/diagnosis ; Colonic Neoplasms/genetics ; Colonic Neoplasms/secondary ; Genes, BRCA1 ; Genes, BRCA2 ; Humans ; Microsatellite Instability ; Mutation ; Prevalence ; Prognosis ; Prospective Studies ; Rectal Neoplasms/diagnosis ; Rectal Neoplasms/genetics ; Rectal Neoplasms/secondary

المؤلفون: Roth MT; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Cardin DB; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Borazanci EH; HonorHealth Research Institute, Scottsdale, Arizona, USA., Steinbach M; HonorHealth Research Institute, Scottsdale, Arizona, USA., Picozzi VJ; Virginia Mason Hospital and Medical Center, Seattle, Washington, USA., Rosemury A; AdventHealth Tampa, Tampa, Florida, USA., Wadlow RC; Virginia Cancer Specialists, Fairfax, Virginia, USA., Newman RA; MD Anderson Cancer Center, Houston, Texas, USA., Berlin J; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

المصدر: The oncologist [Oncologist] 2020 Oct; Vol. 25 (10), pp. e1446-e1450. Date of Electronic Publication: 2020 Jul 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Pancreatic Neoplasms*/drug therapy, Antineoplastic Combined Chemotherapy Protocols ; Bayes Theorem ; Heterocyclic Compounds, 4 or More Rings/therapeutic use ; Humans

المؤلفون: Goyal L; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Chaudhary SP; Harvard Medical School, Boston, MA, USA. Schaudhary1@mgh.harvard.edu.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA. Schaudhary1@mgh.harvard.edu., Kwak EL; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Abrams TA; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Carpenter AN; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Wolpin BM; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Wadlow RC; Virginia Cancer Specialist, Fairfax, VA, USA., Allen JN; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Heist R; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., McCleary NJ; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Chan JA; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Goessling W; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Schrag D; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ng K; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Enzinger PC; Harvard Medical School, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ryan DP; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA., Clark JW; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.

المصدر: Investigational new drugs [Invest New Drugs] 2020 Oct; Vol. 38 (5), pp. 1533-1539. Date of Electronic Publication: 2020 Jan 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Esophageal Neoplasms/*drug therapy , HSP90 Heat-Shock Proteins/*antagonists & inhibitors , Stomach Neoplasms/*drug therapy , Triazoles/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Drug Resistance, Neoplasm ; Esophageal Neoplasms/mortality ; Female ; Humans ; Male ; Middle Aged ; Stomach Neoplasms/mortality ; Treatment Outcome ; Triazoles/adverse effects

المؤلفون: Al-Hajeili M, Shields AF, Hwang JJ, Wadlow RC, Marshall JL

المصدر: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2017 Apr 15; Vol. 31 (4), pp. 301-12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Print ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

مواضيع طبية MeSH: Decision Making* , Precision Medicine*, Colorectal Neoplasms/*genetics , Colorectal Neoplasms/*therapy, Antibodies, Monoclonal, Humanized/therapeutic use ; Biomarkers, Tumor ; DNA Mismatch Repair ; Dihydrouracil Dehydrogenase (NADP)/genetics ; Glucuronosyltransferase/genetics ; Humans ; Proto-Oncogene Proteins p21(ras)/genetics ; Receptor, ErbB-2/analysis ; Thymidylate Synthase/genetics

المؤلفون: Goyal L; Massachusetts General Hospital Cancer Center, 55 Fruit Street, LH/PB 220, Boston, MA, 02114, USA, lgoyal@partners.org., Wadlow RC, Blaszkowsky LS, Wolpin BM, Abrams TA, McCleary NJ, Sheehan S, Sundaram E, Karol MD, Chen J, Zhu AX

المصدر: Investigational new drugs [Invest New Drugs] 2015 Feb; Vol. 33 (1), pp. 128-37. Date of Electronic Publication: 2014 Sep 24.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular/*drug therapy , HSP90 Heat-Shock Proteins/*antagonists & inhibitors , Liver Neoplasms/*drug therapy , Triazoles/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/metabolism ; Female ; Humans ; Liver/metabolism ; Liver Diseases/metabolism ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Treatment Outcome ; Triazoles/adverse effects ; Triazoles/blood ; Triazoles/pharmacokinetics

المؤلفون: Hong TS; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: tshong1@partners.org., Ryan DP; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Borger DR; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Blaszkowsky LS; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Yeap BY; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Ancukiewicz M; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Deshpande V; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Shinagare S; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Boucher Y; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Wadlow RC; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Kwak EL; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Allen JN; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Clark JW; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Zhu AX; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Ferrone CR; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Mamon HJ; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts., Adams J; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Winrich B; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Grillo T; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Jain RK; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., DeLaney TF; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Fernandez-del Castillo C; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Duda DG; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2014 Jul 15; Vol. 89 (4), pp. 830-8. Date of Electronic Publication: 2014 May 24.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Antimetabolites, Antineoplastic/*therapeutic use , Carcinoma, Pancreatic Ductal/*therapy , Chemoradiotherapy, Adjuvant/*methods , Deoxycytidine/*analogs & derivatives , Fluorouracil/*analogs & derivatives , Pancreatic Neoplasms/*therapy , Proton Therapy/*methods, Aged ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; CA-19-9 Antigen/blood ; Capecitabine ; Carcinoembryonic Antigen/blood ; Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/chemistry ; Carcinoma, Pancreatic Ductal/mortality ; Carcinoma, Pancreatic Ductal/pathology ; Chemoradiotherapy, Adjuvant/mortality ; Deoxycytidine/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Genes, ras/genetics ; Hepatocyte Growth Factor/blood ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/chemistry ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Pancreaticoduodenectomy ; Prognosis ; Prospective Studies ; Proto-Oncogene Proteins/analysis ; Proto-Oncogene Proteins p21(ras) ; Receptors, CXCR/analysis ; ras Proteins/analysis

المؤلفون: Russo AL; Harvard Radiation Oncology Program, Boston, Massachusetts., Borger DR, Szymonifka J, Ryan DP, Wo JY, Blaszkowsky LS, Kwak EL, Allen JN, Wadlow RC, Zhu AX, Murphy JE, Faris JE, Dias-Santagata D, Haigis KM, Ellisen LW, Iafrate AJ, Hong TS

المصدر: Cancer [Cancer] 2014 May 15; Vol. 120 (10), pp. 1482-90. Date of Electronic Publication: 2014 Feb 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: DNA Mutational Analysis* , Mutation*, Adenocarcinoma/*genetics , Biomarkers, Tumor/*genetics , Colonic Neoplasms/*genetics , Proto-Oncogene Proteins B-raf/*genetics , Rectal Neoplasms/*genetics, Adenocarcinoma/chemistry ; Adenocarcinoma/mortality ; Adenocarcinoma/secondary ; Adenomatous Polyposis Coli Protein/genetics ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; Class I Phosphatidylinositol 3-Kinases ; Colonic Neoplasms/chemistry ; Colonic Neoplasms/mortality ; Colonic Neoplasms/pathology ; Female ; GTP Phosphohydrolases/genetics ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genotype ; Humans ; Kaplan-Meier Estimate ; Male ; Membrane Proteins/genetics ; Middle Aged ; Neoplasm Staging ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins B-raf/analysis ; Proto-Oncogene Proteins p21(ras) ; Rectal Neoplasms/chemistry ; Rectal Neoplasms/mortality ; Rectal Neoplasms/pathology ; Retrospective Studies ; Risk Factors ; Tumor Suppressor Protein p53/genetics ; ras Proteins/genetics